Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating Activities:    
Net loss $ (5,810) $ (371)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization [note 4] 154 111
Deferred income tax (recovery) [note 2 and note 4]   (124)
Stock-based compensation [note 7 [c] and note 7 [d]] 378  
Changes in operating assets and liabilities:    
Amounts receivable (21)  
Prepaid expenses and other assets 433 2
Accounts payable 38 417
Accrued liabilities other 528 (64)
Accrued clinical liabilities (95)  
Accrued compensation 292  
Lease obligation 2  
Net cash used in operating activities (4,101) (29)
Financing Activities:    
Proceeds from the sale of preferred stock, common stock and warrants, net of issuance costs 12,193  
Proceeds from exercise of warrants, net of issuance costs 428  
Stockholder loans   20
Proceeds from purchase agreement with Lincoln Park Capital, net of issuance costs 1,280  
Net cash provided by financing activities 13,901 20
Investing Activities:    
Purchase of property and equipment (36)  
Proceeds on disposal of assets 10  
Net cash provided by investing activities (26)  
Net increase (decrease) in cash, cash equivalents and restricted cash 9,774 (9)
Cash, cash equivalents and restricted cash at beginning of the period 5,556 15
Cash, cash equivalents and restricted cash at end of the period $ 15,330 6
Non cash financing activities    
Interest expense accrued but not yet paid   $ 14